How does povidone affect the solubility of poorly soluble drugs?

Poorly soluble drugs pose a significant challenge in the pharmaceutical industry, as their low solubility often leads to poor bioavailability and limited therapeutic efficacy. To address this issue, various strategies have been employed, and one of the most effective approaches is the use of solubility enhancers. Povidone, also known as polyvinylpyrrolidone (PVP), is a widely used pharmaceutical excipient that has shown great potential in improving the solubility of poorly soluble drugs. As a leading povidone supplier, we have witnessed firsthand the transformative impact of povidone on drug solubility, and in this blog, we will explore the mechanisms behind this phenomenon and discuss its implications for the pharmaceutical industry.

Understanding Povidone

Povidone is a synthetic, water-soluble polymer composed of repeating N-vinylpyrrolidone units. It is available in various grades, each with different molecular weights and physical properties, which makes it suitable for a wide range of applications in the pharmaceutical, cosmetic, and food industries. In the pharmaceutical field, povidone is commonly used as a binder, disintegrant, solubilizer, and stabilizer in oral solid dosage forms, as well as a solubilizing agent in parenteral formulations.

One of the key advantages of povidone is its excellent biocompatibility and low toxicity, which makes it a safe and effective excipient for use in pharmaceutical products. Additionally, povidone has a high affinity for water and can form strong hydrogen bonds with drug molecules, which helps to increase their solubility in aqueous media.

Mechanisms of Solubility Enhancement

The solubility enhancement of poorly soluble drugs by povidone can be attributed to several mechanisms, including complexation, micelle formation, and surface adsorption.

Complexation

Povidone can form non-covalent complexes with drug molecules through hydrogen bonding, van der Waals forces, and hydrophobic interactions. These complexes are more soluble in water than the free drug molecules, which leads to an increase in the apparent solubility of the drug. The formation of drug-povidone complexes is influenced by several factors, including the molecular weight of povidone, the concentration of povidone, the pH of the solution, and the chemical structure of the drug.

For example, a study by Li et al. (2018) investigated the complexation of ibuprofen, a poorly soluble nonsteroidal anti-inflammatory drug, with povidone K30. The results showed that the formation of ibuprofen-povidone K30 complexes significantly increased the solubility of ibuprofen in water, and the solubility enhancement was proportional to the concentration of povidone K30. The authors attributed the solubility enhancement to the formation of hydrogen bonds between the carboxyl group of ibuprofen and the carbonyl group of povidone K30.

Micelle Formation

Povidone can also form micelles in aqueous solutions, which are aggregates of surfactant molecules with a hydrophobic core and a hydrophilic shell. The hydrophobic core of the micelles can solubilize poorly soluble drugs, while the hydrophilic shell helps to disperse the drug-loaded micelles in water. The formation of micelles by povidone is influenced by several factors, including the molecular weight of povidone, the concentration of povidone, the temperature of the solution, and the presence of other excipients.

For example, a study by Zhang et al. (2019) investigated the micelle formation of povidone K90 in aqueous solutions and its effect on the solubility of paclitaxel, a poorly soluble anticancer drug. The results showed that povidone K90 formed micelles in water at concentrations above its critical micelle concentration (CMC), and the solubility of paclitaxel increased significantly in the presence of povidone K90 micelles. The authors attributed the solubility enhancement to the solubilization of paclitaxel in the hydrophobic core of the povidone K90 micelles.

Surface Adsorption

Povidone can also adsorb onto the surface of drug particles, which helps to prevent their aggregation and precipitation in aqueous solutions. The adsorption of povidone onto the drug surface can also increase the wettability of the drug particles, which facilitates their dissolution in water. The surface adsorption of povidone is influenced by several factors, including the molecular weight of povidone, the concentration of povidone, the surface properties of the drug particles, and the pH of the solution.

For example, a study by Wang et al. (2020) investigated the surface adsorption of povidone K17 onto the surface of fenofibrate, a poorly soluble lipid-lowering drug, and its effect on the solubility and dissolution rate of fenofibrate. The results showed that povidone K17 adsorbed onto the surface of fenofibrate particles, which increased their wettability and prevented their aggregation. The solubility and dissolution rate of fenofibrate also increased significantly in the presence of povidone K17.

Applications in the Pharmaceutical Industry

The solubility enhancement of poorly soluble drugs by povidone has several applications in the pharmaceutical industry, including the development of oral solid dosage forms, parenteral formulations, and topical formulations.

Oral Solid Dosage Forms

Povidone is commonly used as a solubilizing agent in oral solid dosage forms, such as tablets and capsules, to improve the solubility and bioavailability of poorly soluble drugs. By increasing the solubility of the drug, povidone can enhance its dissolution rate in the gastrointestinal tract, which leads to faster absorption and higher plasma concentrations.

For example, a study by Chen et al. (2021) investigated the use of povidone K30 as a solubilizing agent in the formulation of itraconazole tablets. The results showed that the addition of povidone K30 significantly increased the solubility and dissolution rate of itraconazole, and the bioavailability of itraconazole in rats was also improved.

Parenteral Formulations

Povidone is also used as a solubilizing agent in parenteral formulations, such as injections and infusions, to improve the solubility and stability of poorly soluble drugs. By increasing the solubility of the drug, povidone can prevent its precipitation in the injection solution, which ensures the safety and efficacy of the formulation.

For example, a study by Liu et al. (2022) investigated the use of povidone K90 as a solubilizing agent in the formulation of paclitaxel injections. The results showed that the addition of povidone K90 significantly increased the solubility of paclitaxel in the injection solution, and the stability of the paclitaxel injection was also improved.

Topical Formulations

Povidone is also used as a solubilizing agent in topical formulations, such as creams and ointments, to improve the solubility and penetration of poorly soluble drugs into the skin. By increasing the solubility of the drug, povidone can enhance its diffusion through the stratum corneum, which leads to better therapeutic efficacy.

For example, a study by Zhang et al. (2023) investigated the use of povidone K17 as a solubilizing agent in the formulation of diclofenac sodium creams. The results showed that the addition of povidone K17 significantly increased the solubility and penetration of diclofenac sodium into the skin, and the anti-inflammatory effect of the diclofenac sodium cream was also improved.

Conclusion

In conclusion, povidone is a versatile and effective excipient that can significantly improve the solubility of poorly soluble drugs through complexation, micelle formation, and surface adsorption. The solubility enhancement of poorly soluble drugs by povidone has several applications in the pharmaceutical industry, including the development of oral solid dosage forms, parenteral formulations, and topical formulations. As a leading povidone supplier, we are committed to providing high-quality povidone products to meet the needs of the pharmaceutical industry. If you are interested in learning more about our povidone products or would like to discuss potential applications, please do not hesitate to contact us for procurement and negotiation. We look forward to working with you to develop innovative solutions for improving the solubility and bioavailability of poorly soluble drugs.

References

Chen, X., et al. (2021). Enhancement of itraconazole solubility and bioavailability by solid dispersion with povidone K30. International Journal of Pharmaceutics, 602, 120677.
Li, Y., et al. (2018). Solubility enhancement of ibuprofen by complexation with polyvinylpyrrolidone K30. Journal of Pharmaceutical Sciences, 107(6), 1712-1719.
Liu, Y., et al. (2022). Solubilization and stabilization of paclitaxel injection by polyvinylpyrrolidone K90. Journal of Drug Delivery Science and Technology, 74, 103401.
Wang, H., et al. (2020). Enhancement of fenofibrate solubility and dissolution rate by surface adsorption of polyvinylpyrrolidone K17. Journal of Pharmaceutical and Biomedical Analysis, 186, 113387.
Zhang, J., et al. (2019). Solubilization of paclitaxel by polyvinylpyrrolidone K90 micelles. Colloids and Surfaces B: Biointerfaces, 178, 127-133.
Zhang, L., et al. (2023). Enhancement of diclofenac sodium solubility and skin penetration by polyvinylpyrrolidone K17 in cream formulation. International Journal of Pharmaceutics, 633, 122878.